By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company LadRx Corporation

LadRx Corporation (LADX)

OTC Currency in USD
$1.30
-$0.11
-7.80%
Last Update: 3 Sept 2025, 19:07
$643.62K
Market Cap
-0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.46 - $2.80
52 Week Range

LADX Stock Price Chart

Explore LadRx Corporation interactive price chart. Choose custom timeframes to analyze LADX price movements and trends.

LADX Company Profile

Discover essential business fundamentals and corporate details for LadRx Corporation (LADX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

29 Mar 1989

Employees

2.00

CEO

Stephen Snowdy

Description

LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

LADX Financial Timeline

Browse a chronological timeline of LadRx Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 May 2026

Upcoming earnings on 26 Mar 2026

Upcoming earnings on 12 Nov 2025

Earnings released on 12 Aug 2025

Earnings released on 14 May 2025

EPS came in at -$1.45 .

Earnings released on 28 Mar 2025

EPS came in at $0.67 .

Earnings released on 14 Nov 2024

EPS came in at -$1.67 .

Earnings released on 14 Aug 2024

EPS came in at -$2.59 .

Earnings released on 15 May 2024

EPS came in at $0.38 .

Earnings released on 27 Mar 2024

EPS came in at -$1.77 , while revenue for the quarter reached $17.75K .

Earnings released on 14 Nov 2023

EPS came in at -$1.65 .

Earnings released on 14 Aug 2023

EPS came in at $6.45 .

Stock split effective on 18 May 2023

Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 15 May 2023

EPS came in at -$3.00 .

Earnings released on 20 Mar 2023

EPS came in at -$2.00 .

Earnings released on 10 Nov 2022

EPS came in at -$3.00 .

Earnings released on 30 Jun 2022

EPS came in at -$1.79 .

Earnings released on 31 Mar 2022

EPS came in at -$3.32 .

Earnings released on 31 Dec 2021

EPS came in at -$24.02 .

Earnings released on 30 Sept 2021

EPS came in at -$4.41 .

Earnings released on 30 Jun 2021

EPS came in at -$3.22 .

Earnings released on 31 Mar 2021

EPS came in at -$3.51 .

Earnings released on 31 Dec 2020

EPS came in at -$4.07 .

Earnings released on 30 Sept 2020

EPS came in at -$7.88 .

LADX Stock Performance

Access detailed LADX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run